Vir Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Vir BiotechnologyDec 18 13:00

Vir Gets FDA Breakthrough Therapy Status for Two Drugs

Seeking AlphaDec 13 06:03

Express News | Vir Biotechnology Inc - Phase 3 Eclipse Program to Begin in First Half of 2025

BreakingsDec 13 05:05

Express News | Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA Prime Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta

BreakingsDec 13 05:05

Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta

Vir BiotechnologyDec 12 13:00

Loss-making Vir Biotechnology (NASDAQ:VIR) Has Seen Earnings and Shareholder Returns Follow the Same Downward Trajectory Over Past -80%

Simply Wall StDec 10 20:18